Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7222)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2018 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yoo GS, Yu JI, Park HC. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives. World J Gastroenterol 2018; 24(28): 3090-3100 [PMID: 30065555 DOI: 10.3748/wjg.v24.i28.3090] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i28/3090.htm |
| Number | Citing Articles |
| 1 |
David Brasse, Hélène Burckel, Patrice Marchand, Marc Rousseau, Ali Ouadi, Marie Vanstalle, Christian Finck, Patrice Laquerriere, Frédéric Boisson. Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma. Molecular Imaging and Biology 2021; 23(5): 724 doi: 10.1007/s11307-021-01602-3
|
| 2 |
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment Criteria. Seminars in Ultrasound, CT and MRI 2021; 42(4): 318 doi: 10.1053/j.sult.2021.04.004
|
| 3 |
_ _, Oszkár Hahn, Attila Szijártó, Damján Pekli, András Fülöp, Bálint Kokas, Dávid Bárdos, Csilla András, Péter Bartek, István Battyáni, János Bezsilla, György Bodoky, Attila Bursics, Magdolna Dank, Zsófia Dankovics, Ákos Deák Pál, Kristóf Dede, Gyula Demeter, Attila Doros, Ibolyka Dudás, Zsófia Egyed, Róbert Farkas, Zsuzsanna Gerlei, Tamás Györke, Krisztina Hagymási, Oszkár Hahn, Erika Hitre, József Hőhn, Viktor Jancsik, Zsolt Káposztás, István Király, András Kiss, László Kóbori, Péter Kupcsulik, Gábor Lakatos, István Lázár, Tamás Lóderer, Endre Nagy, Attila Oláh, Péter Pajor, András Papp, Gabriella Pár, Mihály Patyánik, Damján Pekli, Ágota Petrányi, András Petri, László Piros, János Schuller, László Sikorszki, József Szabó, Eszter Székely, Attila Szijártó, Andrea Szombati, László Torday, Judit Tóth, Lajos Barna Tóth, Edit Dósa, László Harsányi, Zsolt Horváth, Gábor István, László Landherr, György Lázár, Gabriella Lengyel, József Lővey, László Mangel, Pál Maurovich Horváth, Balázs Nemes, András Palkó, Zsuzsa Schaff, Ferenc Szalay, Ákos Szűcs, András Vereczkei. A hepatocellularis carcinoma komplex kezelése.. Orvosi Hetilap 2022; 162(Supplement-2): 2 doi: 10.1556/650.2021.32431
|
| 4 |
Gagan Saini, Rashmi Shukla, Kanika S. Sood, Sujit K. Shukla, Ritu Chandra. Role of Proton Beam Therapy in Current Day Radiation Oncology Practice. Asian Journal of Oncology 2020; 6: 097 doi: 10.1055/s-0040-1713703
|
| 5 |
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park, Dongho Hyun, Woo Kyoung Jeong, Ho Yeong Lim, Moon Seok Choi, Sang Yun Ha. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?. Cancers 2020; 12(9): 2395 doi: 10.3390/cancers12092395
|
| 6 |
Kyung Su Kim, Hong-Gyun Wu. Who Will Benefit from Charged-Particle Therapy?. Cancer Research and Treatment 2021; 53(3): 621 doi: 10.4143/crt.2021.299
|
| 7 |
Ira Nofi Santika, Rida Siti Nur Mahmudah, Restu Widiatmono, Yohannes Sardjono, Zuhdi Ismail, Gede Sutresna Wijaya, Isman Mulyadi Triatmoko, Yaser Kasesaz. Dose analysis of proton beam therapy in hepatocellular carcinoma using PHITS version 3.20. Journal of Physics: Conference Series 2023; 2498(1): 012027 doi: 10.1088/1742-6596/2498/1/012027
|
| 8 |
Mina Răileanu, Mihai Straticiuc, Decebal-Alexandru Iancu, Radu-Florin Andrei, Mihai Radu, Mihaela Bacalum. Proton irradiation induced reactive oxygen species promote morphological and functional changes in HepG2 cells. Journal of Structural Biology 2022; 214(4): 107919 doi: 10.1016/j.jsb.2022.107919
|
| 9 |
Hikaru Niitsu, Masashi Mizumoto, Yinuo Li, Masatoshi Nakamura, Toshiki Ishida, Takashi Iizumi, Takashi Saito, Haruko Numajiri, Hirokazu Makishima, Kei Nakai, Yoshiko Oshiro, Kazushi Maruo, Hideyuki Sakurai. Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma. Cancers 2024; 16(2): 357 doi: 10.3390/cancers16020357
|
| 10 |
Gyu Sang Yoo, Won-Gyun Ahn, Shin-Yeong Kim, Wonseok Kang, Changhoon Choi, Hee Chul Park. Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study. Clinical and Molecular Hepatology 2021; 27(1): 144 doi: 10.3350/cmh.2020.0095
|
| 11 |
Beau B. Toskich, Ryan E. Bailey, Sadeer J. Alzubaidi, Zlatko Devcic, Gregory T. Frey, Andrew R. Lewis, Michael R. Moynagh, Kabir Mody, Charles A. Ritchie, Terence T. Sio, Tushar Patel, Ricardo Paz-Fumagalli. Advances in the Ablative Management of Hepatocellular Carcinoma. Advances in Clinical Radiology 2019; 1: 215 doi: 10.1016/j.yacr.2019.04.007
|
| 12 |
Shu Xing, Jungwook Shin, Jennifer Pursley, Camilo M Correa-Alfonso, Nicolas Depauw, Sean Domal, Julia Withrow, Wesley Bolch, Clemens Grassberger, Harald Paganetti. A dynamic blood flow model to compute absorbed dose to circulating blood and lymphocytes in liver external beam radiotherapy. Physics in Medicine & Biology 2022; 67(4): 045010 doi: 10.1088/1361-6560/ac4da4
|
| 13 |
Gyu Sang Yoo, Jeong Il Yu, Sungkoo Cho, Sang Hoon Jung, Youngyih Han, Seyjoon Park, Yoonjin Oh, Boram Lee, Hee Chul Park, Do Hoon Lim, Moon Seok Choi, Hojeong Won. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma. Radiotherapy and Oncology 2020; 146: 187 doi: 10.1016/j.radonc.2020.02.019
|
| 14 |
Chien Peter Chen. Role of External Beam Radiotherapy in Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4): 701 doi: 10.1016/j.cld.2020.07.006
|
| 15 |
Shirley Lewis, Laura Dawson, Aisling Barry, Teodor Stanescu, Issa Mohamad, Ali Hosni. Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity. JHEP Reports 2022; 4(8): 100498 doi: 10.1016/j.jhepr.2022.100498
|
| 16 |
Hiroaki Takahashi, Yuta Sekino, Kensaku Mori, Toshiyuki Okumura, Katsuhiro Nasu, Kuniaki Fukuda, Sota Masuoka, Takashi Iizumi, Naoyuki Hasegawa, Hideyuki Sakurai, Manabu Minami. Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT. The British Journal of Radiology 2020; 93(1105): 20190375 doi: 10.1259/bjr.20190375
|
| 17 |
Miao-Fen Chen, Ping-Tsung Chen, Ching-Chuan Hsieh, Chih-Chi Wang. Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular Carcinoma. Cells 2023; 12(2): 332 doi: 10.3390/cells12020332
|
| 18 |
Esben Schjødt Worm, Rune Hansen, Morten Høyer, Britta Weber, Hanna Mortensen, Per Rugaard Poulsen. Uniform versus non-uniform dose prescription for proton stereotactic body radiotherapy of liver tumors investigated by extensive motion-including treatment simulations. Physics in Medicine & Biology 2021; 66(20): 205009 doi: 10.1088/1361-6560/ac2880
|
| 19 |
Hiroaki Takahashi, Kensaku Mori, Yuta Sekino, Toshiyuki Okumura, Takashi Hiyama, Kuniaki Fukuda, Naoyuki Hasegawa, Masafumi Sakai, Shunsuke Kikuchi, Yohei Takei, Takashi Iizumi, Hideyuki Sakurai, Manabu Minami. Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/3580379
|
| 20 |
Tai‐Ze Yuan, Ze‐Jiang Zhan, Chao‐Nan Qian. New frontiers in proton therapy: applications in cancers. Cancer Communications 2019; 39(1): 1 doi: 10.1186/s40880-019-0407-3
|
| 21 |
Chiao-Yi CHEN, Bing-Shen HUANG, Ji-Hong HONG, Joseph Tung-Chieh CHANG, Min-Chi CHEN, Woung-Ru TANG, Shiow-Ching SHUN, Mei-Ling CHEN. Persistent Fatigue in Patients With Hepatocellular Carcinoma Receiving Radiotherapy. Journal of Nursing Research 2024; 32(2): e319 doi: 10.1097/jnr.0000000000000606
|
| 22 |
Pei-Yi Lee, Bing-Shen Huang, Shen-Hao Lee, Tsz-Yui Chan, Eric Yen, Tsair-Fwu Lee, I-Chun Cho. An investigation into the impact of volumetric rescanning and fractionation treatment on dose homogeneity in liver cancer proton therapy. Journal of Radiation Research 2024; 65(1): 100 doi: 10.1093/jrr/rrad093
|
| 23 |
Suresh Subramanian, Madhava B. Mallia, Ajit S. Shinto, Ashwathy S. Mathew. Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies. Oncology and Therapy 2021; 9(2): 273 doi: 10.1007/s40487-021-00154-4
|
| 24 |
Bong Kyung Bae, Jeong Il Yu, Hee Chul Park, Myung Ji Goh, Yong-Han Paik. Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017. Radiation Oncology Journal 2023; 41(2): 98 doi: 10.3857/roj.2023.00353
|
| 25 |
Dmitry Dzhuzha. Charged particles therapy in radiation oncology. Radiation Diagnostics, Radiation Therapy 2020; (1): 39 doi: 10.37336/2707-0700-2020-1-4
|
| 26 |
Yu-Lun Tsai, Hideyuki Takei, Takashi Iizumi, Toshiyuki Okumura, Yuta Sekino, Haruko Numajiri, Hitoshi Ishikawa, Takeji Sakae, Hideyuki Sakurai. Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma. Journal of Radiation Research 2021; 62(1): 133 doi: 10.1093/jrr/rraa098
|
| 27 |
Jana M. Kobeissi, Lara Hilal, Charles B. Simone, Haibo Lin, Christopher H. Crane, Carla Hajj. Proton Therapy in the Management of Hepatocellular Carcinoma. Cancers 2022; 14(12): 2900 doi: 10.3390/cancers14122900
|
| 28 |
Saber Nankali, Esben Schjødt Worm, Jakob Borup Thomsen, Line Bjerregaard Stick, Jenny Bertholet, Morten Høyer, Britta Weber, Hanna Rahbek Mortensen, Per Rugaard Poulsen. Intrafraction tumor motion monitoring and dose reconstruction for liver pencil beam scanning proton therapy. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1112481
|
| 29 |
So-Young Chun, Kyung-Soo Nam, Kyu-Shik Lee. Proton Beam Induces P53-mediated Cell Cycle Arrest in HepG2 Hepatocellular Carcinoma Cells. Biotechnology and Bioprocess Engineering 2020; 25(2): 141 doi: 10.1007/s12257-019-0390-1
|
| 30 |
Boram Lee, Sungkoo Cho, Hee Chul Park, Sang-Won Kang, Jae-Sung Kim, Jin-Beom Chung. Assessment of dose perturbations for metal stent in photon and proton radiotherapy plans for hepatocellular carcinoma. Radiation Oncology 2022; 17(1) doi: 10.1186/s13014-022-02100-8
|
| 31 |
Changhoon Choi, Arang Son, Ga-Haeng Lee, Sung-Won Shin, Sohee Park, Sang Hee Ahn, Yoonsun Chung, Jeong Il Yu, Hee Chul Park, Yi-Hsien Hsieh. Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction. PLOS ONE 2019; 14(6): e0218049 doi: 10.1371/journal.pone.0218049
|
| 32 |
Chien Pong Chen. Role of Radiotherapy in the Treatment of Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00060
|
| 33 |
Jen-Yu Cheng, Chieh-Min Liu, Yu-Ming Wang, Hsuan-Chih Hsu, Eng-Yen Huang, Tzu-Ting Huang, Ching-Hsin Lee, Sheng-Ping Hung, Bing-Shen Huang. Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis. Radiation Oncology 2020; 15(1) doi: 10.1186/s13014-020-01605-4
|
| 34 |
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, Hee Chul Park. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(20): 2416-2429 doi: 10.3748/wjg.v25.i20.2416
|
| 35 |
Jihye Kim, Gyu Sang Yoo, Dong Hyun Sinn, Hee Chul Park, Kwang Cheol Koh. Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma. Journal of Liver Cancer 2019; 19(2): 136 doi: 10.17998/jlc.19.2.136
|
| 36 |
Perla Chami, Youssef Diab, Danny N. Khalil, Hassan Azhari, William R. Jarnagin, Ghassan K. Abou-Alfa, James J. Harding, Joseph Hajj, Jennifer Ma, Maria El Homsi, Marsha Reyngold, Christopher Crane, Carla Hajj. Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(23): 16773 doi: 10.3390/ijms242316773
|
| 37 |
Wenxiu Zhao, Xiaobin Jiang, Karrin Weisenthal, Jun Ma, Erin M. Botticelli, Yunli Zhou, E. Tessa Hedley-Whyte, Baiyao Wang, Brooke Swearingen, Roy J. Soberman, Anne Klibanski, Xun Zhang. High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.875122
|
| 38 |
Xiao Li, Zhaosheng Ma, Linhang Mei. Comprehensive analysis of UBE2C expression and its potential roles and mechanisms in hepatocellular carcinoma. Aging 2023; doi: 10.18632/aging.204792
|
| 39 |
Jing Yang, Jiali Wang, Jialin Luo. Decreased IL-6 induces sensitivity of hepatocellular carcinoma cells to sorafenib. Pathology - Research and Practice 2019; 215(10): 152565 doi: 10.1016/j.prp.2019.152565
|
| 40 |
Bong Kyung Bae, Hee Chul Park, Jeong Il Yu, Gyu Sang Yoo, Dong Hyun Sinn, Moon Seok Choi, Joo Hyun Oh. Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.928119
|